BioNTech SE

Stocks

BNTX

US09075V1026

Market Closed - Nasdaq 00:00:00 22/08/2026 +04			5-day change	1st Jan Change
116.57 ^USD	+5.12%		+25.22%	+22.45%

08-21	European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading	MT
08-21	BioNTech, neoantigens by proxy

Transcript : BioNTech SE - Special Call

Published on 11/17/2025 at 10:08 pm +04 - Modified on 11/18/2025 at 02:40 am +04

S&P Capital IQ

Presenter Speech
Unknown Executive (Executives)

[Audio Gap] by Annemarie Hanekamp, our Chief Commercial Officer. So with that, I'm excited to hand over to Ugur and welcome him to the stage to talk to

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about BioNTech SE

08-21	European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading	MT
08-21	BioNTech, neoantigens by proxy
08-20	European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	MT
08-20	Cancer vaccines finally garner the spotlight
08-20	BioNTech SE : Jefferies keeps its Buy rating	ZD
08-20	BioNTech SE Presents New Clinical Data and Pipeline Updates for Lung Cancer Treatment At Wclc 2026	CI
08-20	Will Moderna Wake Up the Health Care Sector?
08-20	Moderna, Merck breakthrough could usher in wave of cancer vaccines	RE
08-19	US stock futures steady after tech slump; investors focus on Middle East tensions	RE
08-19	Wall St recovers as yields ease; Moderna lifts healthcare stocks	RE
08-19	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT
08-19	Wall St up after tech selloff as yields retreat; Moderna surges	RE
08-11	Tango Therapeutics Q2 Net Loss Widens	MT
08-06	European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading	MT
08-05	Berenberg Bank Adjusts BioNTech SE Price Target to $132 From $140, Maintains Buy Rating	MT